Ina Haendle

1.9k total citations · 1 hit paper
9 papers, 1.6k citations indexed

About

Ina Haendle is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Ina Haendle has authored 9 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 4 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Ina Haendle's work include Immunotherapy and Immune Responses (7 papers), T-cell and B-cell Immunology (4 papers) and CAR-T cell therapy research (4 papers). Ina Haendle is often cited by papers focused on Immunotherapy and Immune Responses (7 papers), T-cell and B-cell Immunology (4 papers) and CAR-T cell therapy research (4 papers). Ina Haendle collaborates with scholars based in Germany, United States and Belgium. Ina Haendle's co-authors include Gerold Schuler, Christian Maczek, Claudia Röder, Eckhart Kämpgen, Peter Von Den Driesch, Alexander Enk, Petra Keikavoussi, Detlef Dieckmann, Eva B. Bröcker and Armin Bender and has published in prestigious journals such as The Journal of Experimental Medicine, Blood and The Journal of Immunology.

In The Last Decade

Ina Haendle

9 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Vaccination with Mage-3a1 Peptide–Pulsed Mature, Monocyte-Derived Dendritic Cells Expands Specific Cytotoxic T Cells and Induces Regression of Some Metastases in Advanced Stage IV Melanoma

1999 1.0k citations Beatrice Thurner, Ina Haendle et al. The Journal of Experimental Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ina Haendle Germany	8	1.4k	690	607	91	78	9	1.6k
Beatrice Thurner Germany	5	1.4k 1.0×	653 0.9×	532 0.9×	99 1.1×	53 0.7×	5	1.5k
Dania Caron United States	16	1.3k 0.9×	319 0.5×	454 0.7×	60 0.7×	58 0.7×	21	1.5k
Arabella Mazzocchi Italy	18	1.1k 0.7×	489 0.7×	498 0.8×	82 0.9×	76 1.0×	44	1.3k
Susan Burkeholder United States	8	1.3k 0.9×	508 0.7×	592 1.0×	78 0.9×	44 0.6×	10	1.4k
Sarah L. Buchan United Kingdom	18	829 0.6×	392 0.6×	434 0.7×	102 1.1×	65 0.8×	26	1.1k
B. Van den Eynde Belgium	7	1.4k 1.0×	499 0.7×	640 1.1×	154 1.7×	62 0.8×	14	1.6k
Marjolein Sluijter Netherlands	21	1.2k 0.8×	364 0.5×	768 1.3×	60 0.7×	99 1.3×	38	1.5k
Caroline Boudousquié Switzerland	12	715 0.5×	361 0.5×	409 0.7×	41 0.5×	46 0.6×	17	1.1k
John Copier United Kingdom	15	449 0.3×	379 0.5×	270 0.4×	60 0.7×	129 1.7×	29	902
Daniel Hirschhorn-Cymerman United States	15	1.4k 1.0×	272 0.4×	979 1.6×	87 1.0×	55 0.7×	22	1.7k

Countries citing papers authored by Ina Haendle

Since Specialization

Citations

This map shows the geographic impact of Ina Haendle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ina Haendle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ina Haendle more than expected).

Fields of papers citing papers by Ina Haendle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ina Haendle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ina Haendle. The network helps show where Ina Haendle may publish in the future.

Co-authorship network of co-authors of Ina Haendle

This figure shows the co-authorship network connecting the top 25 collaborators of Ina Haendle. A scholar is included among the top collaborators of Ina Haendle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ina Haendle. Ina Haendle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Groß, Stefanie, Michael Erdmann, Ina Haendle, et al.. (2017). Twelve-year survival and immune correlates in dendritic cell–vaccinated melanoma patients. JCI Insight. 2(8). 67 indexed citations

2.

Baur, Andreas S., Manfred B. Lutz, Luca Beltrame, et al.. (2013). Denileukin diftitox (ONTAK) induces a tolerogenic phenotype in dendritic cells and stimulates survival of resting Treg. Blood. 122(13). 2185–2194. 54 indexed citations

3.

Sun, Zhaojun, Ina Haendle, Beatrice Schuler‐Thurner, et al.. (2007). Tumor-Reactive CD4+ T Cell Responses to the Melanoma-Associated Chondroitin Sulphate Proteoglycan in Melanoma Patients and Healthy Individuals in the Absence of Autoimmunity. The Journal of Immunology. 178(12). 7703–7709. 17 indexed citations

4.

Hertl, Michael, Ina Haendle, & Gerold Schuler. (2005). Rapid improvement of recalcitrant disseminated granuloma annulare upon treatment with the tumour necrosis factor-alpha inhibitor, infliximab. British Journal of Dermatology. 152(3). 552–555. 54 indexed citations

5.

Haendle, Ina, et al.. (2004). Anul�re Erytheme mit Juckreiz bei einer 69-j�hrigen Patientin. Der Hautarzt. 56(4). 378–380. 1 indexed citations

6.

Berger, Thomas, Ina Haendle, David Schrama, et al.. (2004). Circulation and homing of melanoma‐reactive T cells to both cutaneous and visceral metastases after vaccination with monocyte‐derived dendritic cells. International Journal of Cancer. 111(2). 229–237. 33 indexed citations

7.

Dieckmann, Detlef, Petra Keikavoussi, Armin Bender, et al.. (2000). Mage-3 and Influenza-Matrix Peptide-Specific Cytotoxic T Cells Are Inducible in Terminal Stage HLA-A2.1+ Melanoma Patients by Mature Monocyte-Derived Dendritic Cells. The Journal of Immunology. 165(6). 3492–3496. 173 indexed citations

8.

Berger, Thomas, Christian Maczek, Claudia Röder, et al.. (2000). A method for the production of cryopreserved aliquots of antigen-preloaded, mature dendritic cells ready for clinical use. Journal of Immunological Methods. 245(1-2). 15–29. 134 indexed citations

9.

Thurner, Beatrice, Ina Haendle, Claudia Röder, et al.. (1999). Vaccination with Mage-3a1 Peptide–Pulsed Mature, Monocyte-Derived Dendritic Cells Expands Specific Cytotoxic T Cells and Induces Regression of Some Metastases in Advanced Stage IV Melanoma. The Journal of Experimental Medicine. 190(11). 1669–1678. 1020 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact